COM701 in Combination With BMS-986207 and Nivolumab in Subjects With Advanced Solid Tumors.

Clinical trial NCT04570839 · COMPLETED

Trial details

NCT number: NCT04570839
Sponsor: Compugen Ltd
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Endometrial Neoplasms Ovarian Cancer Solid Tumor Head and Neck Cancer

Start date: 2020-08-31
Primary completion: 2024-05-15
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.